| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | 0.062 | 0.4 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.4 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.4 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.4 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.4 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.4 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |